Form D · Pharmaceuticals

Sigma Pharmaceuticals Ltd

South Croydon, Victoria, C3 · CIK 0001472870

Offering snapshot reported Sep 24, 2009 · SEC filing

Reported sold
$18.2M
Offering amount: $18.2M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 23, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 24, 2009Initial$18,215,562No comparison13SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-134695

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Deutsche Bank Securities Inc.2525Deutsche Bank Securities Inc. · CRD 2525

Source: Form D, filed Sep 24, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Barrie Executive
David S Bayes Director
Geoffrey D W Curlewis Director
Elmo De Alwis Director
Robert Ellis Executive
Ian Finlay Executive
Brian Jamieson Director
Keith Jeffs Executive
Michael Long Executive
Sue Morgan Dethick Executive
Linda B Nicholls Director
William J Scott Director
Mark Smith Executive
John W Stocker Ao Director
Peter Tilley Executive
Jackie Toh Executive
Craig Tomlinson Executive
Steve Waller Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
96 Merrindale Drive
South Croydon, Victoria, C3, 3136